Ziolkowska-Banasik, D.; Zawadzinska-Halat, K.; Basta, P.; Pastuszczak, M.
Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12. J. Clin. Med. 2025, 14, 7293.
https://doi.org/10.3390/jcm14207293
AMA Style
Ziolkowska-Banasik D, Zawadzinska-Halat K, Basta P, Pastuszczak M.
Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12. Journal of Clinical Medicine. 2025; 14(20):7293.
https://doi.org/10.3390/jcm14207293
Chicago/Turabian Style
Ziolkowska-Banasik, Dominika, Kamila Zawadzinska-Halat, Paulina Basta, and Maciej Pastuszczak.
2025. "Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12" Journal of Clinical Medicine 14, no. 20: 7293.
https://doi.org/10.3390/jcm14207293
APA Style
Ziolkowska-Banasik, D., Zawadzinska-Halat, K., Basta, P., & Pastuszczak, M.
(2025). Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12. Journal of Clinical Medicine, 14(20), 7293.
https://doi.org/10.3390/jcm14207293